Technique helps manage heart patients

Article

A method refined by Siemens Medical Solutions for assessing a patient's risk for coronary heart disease was presented at the American College of Cardiology meeting. The technique combines use of the Prospective Cardiovascular Muenster Calculator and a

A method refined by Siemens Medical Solutions for assessing a patient's risk for coronary heart disease was presented at the American College of Cardiology meeting. The technique combines use of the Prospective Cardiovascular Muenster Calculator and a multidetector CT examination of the heart to identify individuals at high risk for a future coronary event according to their PROCAM Score. The technique was refined in collaboration with the International Task Force for Prevention of Coronary Heart Disease. The PROCAM Calculator looks at factors that contribute to the risk of heart attack: age, gender, blood lipids, blood pressure, family history, smoking, and diabetes. The score helps quantify risk reduction via lifestyle adjustments and LDL cholesterol-targeted treatment. Multidetector cardiac CT exams visualize constrictions and plaque lesions inside the coronary vessels, potentially allowing for early, targeted treatment of high-risk individuals.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.